Wockhardt will exit its loss-making US generic business to focus on antibiotics and diabetes care. The company filed for ...

The decision follows years of financial losses in the US generics business, including loss of nearly $8 million in FY 2025, ...

Trying to quickly turn a browser extension into a new revenue stream can backfire—common missteps can damage trust and tank ...

Wockhardt says its US generics business has been loss-making for several years, incurring a loss of nearly $8 million in FY25 alone.

Are you making a common decor mistake that's making your bathroom look boring and cookie cutter? Find out what the mistake is and how to avoid it.

Mumbai: Wockhardt has announced a significant strategic realignment of its U.S. business, marking an exit from the generic ...

Wockhardt Ltd has decided to shut down its loss-making US generics business to channel its energy and funds into developing ...